Llwytho...
c-Met as a Target for Personalized Therapy
MET and its ligand HGF are involved in many biological processes, both physiological and pathological, making this signaling pathway an attractive therapeutic target in oncology. Downstream signaling effects are transmitted via mitogen-activated protein kinase (MAPK), PI3K (phosphoinositide 3-kinase...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Transl Oncogenomics |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Libertas Academica
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4659440/ https://ncbi.nlm.nih.gov/pubmed/26628860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/TOG.S30534 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|